Irwin Naturals Acquires Kentucky Ketamine Clinic

Serenity is expected to add $3 million in EBITDA to Irwin's financials.

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) continued its expansion spree with its acquisition of Serenity Health LLC, a ketamine clinic in Louisville, Kentucky.

Total consideration will be paid in upfront and deferred consideration. The deal also includes contingent payments based on milestones related to expansion and profitability goals.

The acquisition marks two key milestones in Irwin’s Emergence clinics growth strategy in the mental health industry. First, the acquisition is expected to be immediately accretive by adding an estimated $3 million in projected EBITDA, increasing the company’s annualized EBITDA by double digits. Second, the addition of this clinic further demonstrates Irwin’s ability to attract profitable clinics as part of its goal to establishing the world’s largest network of psychedelic mental health clinics.

The acquisition of Serenity Health brings the total number of clinics under the Irwin Naturals Emergence umbrella either under a definitive agreement, the Braxia letter of intent, or acquired to 22, including existing clinics in Florida, Vermont, New Hampshire, Iowa, and Georgia.

Irwin announced its intent to acquire Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF) last month, though the price tag of that deal is yet to be determined. That move will expand Irwin’s operating footprint in both the U.S. and Canada.

One comment

  • LSD Sheets

    February 24, 2023 at 7:52 am

    How Ketamine Works
    Ketamine is considered a “dirty drug”. This doesn’t mean the drug is toxic or poisonous — it refers to the specificity of the drug on its target receptors.

    Ideally, a pharmaceutical targets one specific receptor to cause its effect. This makes its effects predictable and easier to study and understand. These drugs are precise and don’t cause any overflow effects on unrelated or irrelevant receptors.

    Ketamine, on the other hand, is messy — it activates several different types of receptors, each with a different result. Ketamine stimulates some receptors and inhibits others.

    This makes ketamine very difficult to study and understand. It’s also what makes this compound so useful for complex conditions like depression.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

Body and Mind Reports Slumping Sales as New Dispensaries Come Online

@GreenMarketRpt – 2 days

Planet 13’s Financial Numbers Down Across the Board for 2022, Losses Jump 152%

@GreenMarketRpt – 2 days

Atai Life Sciences Losses Shrunk in 2022 Amid Restructuring Bid

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.